Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Ranibizumab for PCV
NCT01469156Phase 2Completed
- Sponsor
- Southeast Retina Center
- Start
- Sep 2011
- Primary completion
- Feb 2015
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in polypoidal choroidal vasculopathy (PCV), sponsored by Southeast Retina Center. Started Sep 2011; status: completed.
02
Drugs
ranibizumab
03
Conditions
polypoidal choroidal vasculopathy (PCV)
Beyond the preview
Go deeper on NCT01469156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01469156.